provider portal
Wesper Journal
Did you know that sleep disorders, like sleep apnea, can significantly impact your health if not diagnosed and treated properly? Understanding how to diagnose these conditions is crucial for effective treatment. This article explores two main methods for diagnosing sleep...
Continue reading
Zepbound (tirzepatide) has received FDA approval for the treatment of obstructive sleep apnea, now included in Medicare coverage to help manage the condition alongside obesity. This approval marks a shift towards a holistic approach, combining medication with real-time monitoring for...
Continue reading
GLP-1 therapies, such as Zepbound (tirzepatide), address obstructive sleep apnea by aiding weight management, thereby reducing airway pressure and improving respiratory health. Wesper's wearable technology enhances treatment by providing continuous monitoring, allowing for timely adjustments to therapy plans. FDA’s Landmark...
Continue reading
Wesper is poised to change sleep medicine alongside GLP-1 by integrating advanced sleep monitoring technology with GLP-1 therapies, enabling comprehensive and personalized treatment for sleep apnea. This combination offers real-time treatment optimization and enhanced patient outcomes, marking a significant advancement...
Continue reading
Many individuals with ADHD also experience sleep apnea, which exacerbates ADHD symptoms but can be significantly alleviated through CPAP therapy and lifestyle modifications. Personal stories highlight the transformative impact of treatment, leading to improved focus, energy, and overall well-being. 1....
Continue reading
